What is Viyash Scientific Ltd (VIYASH) share price return in the past 10 years?

Viyash Scientific Ltd share price has appreciated 6.1% annually (CAGR) over the past ten years.

What is the share price of Viyash Scientific Ltd (VIYASH)?

Company share prices are keep on changing according to the market conditions. The current trading price of Viyash Scientific Ltd (VIYASH) on 05-Jun-2026 16:59:59 at 16:59 is 255.15.

What is the P/E ratio of Viyash Scientific?

The latest standalone P/E ratio of Viyash Scientific as of 05-Jun-2026 is 143.49.

What is the P/B ratio of Viyash Scientific Ltd (VIYASH)?

The latest standalone P/B ratio of Viyash Scientific Ltd (VIYASH) as of 05-Jun-2026 is 3.41.

What is the 52-week high and low of Viyash Scientific Ltd (VIYASH)?

The 52-week high of Viyash Scientific Ltd (VIYASH) is Rs. 277.05 and the 52-week low is Rs. 166.20.

Viyash Scientific Ltd (VIYASH) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Viyash Scientific Ltd (VIYASH)
Brand: Viyash Scientific

Viyash Scientific Ltd (VIYASH)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 512529 NSE: VIYASH Pharmaceuticals & Drugs | Small Cap | Viyash Scientific Share Price

Viyash Scientific Ltd (VIYASH)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 512529 NSE: VIYASH Pharmaceuticals & Drugs | Small Cap | Viyash Scientific Share Price

Key Metrics

Valuation Multiples

Market Cap

₹10,887 Cr.

Current Price

₹255.2

52-Week Low / High

₹166 / 277

TTM EPS

₹4.1

TTM Sales

₹3,420 Cr.

Book Value per Share

₹66.6

P/E Ratio

61.41

Lower than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

3.74

Lower than its 5-year historical median

Price to Sales (P/S)

3.18

Higher than its 5-year historical median

EV/EBITDA

15.88

Lower than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

5.44%

Underperforms industry median

Return on Capital Employed (ROCE)

9.30%

Underperforms industry median

Return on Assets (ROA)

2.08%

Operating Profit Margin

10.8%

Net Profit Margin

2.08%

Gross Profit Margin

7.2%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

13.26%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

158.7%

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

61.31%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹2,824 Cr.

Equity

₹87.4 Cr.

Face Value

₹2

All Time Low / High

₹0.40 / 336.40

Viyash Scientific stock performance

Key Ratios

Check Before You Invest

Quality

Somewhat Good

Check detailed performance

Valuation

Fair

Check Valuation charts

Price Trend

Strong

Check Price chart

Q.1 Is Viyash Scientific Ltd a good quality company?

Viyash Scientific Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Viyash Scientific Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Viyash Scientific Ltd vs industry peers?

Viyash Scientific Ltd revenue CAGR is 5.64%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Viyash Scientific Ltd?

Promoters hold 61.31% of the Viyash Scientific Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Viyash Scientific Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 6.6% based on the current price.

DeciZen - make an informed investing decision on Viyash Scientific

Consolidated basis

1. Right Stock

10 Year X-ray Pro

Long Term Prospect

2. Right Price

Price Chart

3. Right Time ⓘ

#Likely Future 5 Year CAGR.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	2.5%	1.1%	4.8%	9.2%	12.6%	16.2%	7%	-9.7%	-0.6%	9.3%	-
Value Creation Index ⓘ	-0.8	-0.9	-0.7	-0.3	-0.1	0.2	-0.5	-1.7	-1.0	-0.3	-
Growth Parameters ⓘ
Sales ⓘ	606	684	848	1,039	1,179	1,362	1,413	1,421	1,370	1,551	3,420
Sales YoY Gr.	-	12.8%	24%	22.6%	13.5%	15.5%	3.8%	0.6%	-3.6%	13.3%	-
Adj EPS ⓘ	-0.8	-0.1	0.2	2.2	3	4	1.5	-4.5	-0.5	1.1	4.1
YoY Gr.	-	NA	NA	1042.1%	36.4%	35.5%	-63.6%	-408.9%	NA	NA	-
BVPS (₹) ⓘ	38.7	39.4	25.9	27.9	27.1	29	26	25.8	23.2	24.3	66.6
Adj Net Profit ⓘ	-19.6	-1.6	4.7	53.6	73.4	99.6	36.4	-112	-12.1	26.7	177
Cash Flow from Ops. ⓘ	-0.1	-7.2	45.2	116	115	115	30.6	16.8	30.6	83.4	-
Debt/CF from Ops. ⓘ	-5782.5	-57.8	6.7	2.8	3	2	10.3	23.7	14.8	5.4	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	11%	5.6%	3.2%	13.3%
Adj EPS ⓘ	NA	-18.4%	-9.8%	NA
BVPSⓘ	-5.1%	-2.2%	-2.2%	4.6%
Share Price	6.1%	-0.4%	51.2%	35.9%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-3.8	-0.2	0.6	7.9	10.5	14.1	5.1	-16.2	-1.8	3.9	8.9
Op. Profit Mgn % ⓘ	9.6	8.5	10.3	12.8	14.9	15.7	7.8	1.7	5.6	10.8	17.7
Net Profit Mgn % ⓘ	-2.9	-0.6	1.7	6	7.3	8	2.8	-8	-0.4	2.4	5.2
Debt to Equity ⓘ	0.3	0.4	0.5	0.5	0.5	0.3	0.5	0.6	0.8	0.7	0.1
Working Cap Days ⓘ	227	275	246	206	190	179	196	199	208	198	106
Cash Conv. Cycle ⓘ	79	93	89	79	73	80	95	102	106	95	56

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	606	684	848	1,039	1,179	1,362	1,413	1,421	1,370	1,551
Operating Expenses ⓘ +	551	641	765	914	1,009	1,152	1,303	1,409	1,308	1,393
Manufacturing Costs	99	70	74	101	108	125	128	129	109	101
Material Costs	299	357	462	543	605	695	793	834	760	812
Employee Cost	87	106	114	146	165	187	231	258	251	281
Other Costs ⓘ	67	107	115	125	131	145	152	187	189	199
Operating Profit ⓘ	55	43	83	125	170	210	109	12	61	159
Operating Profit Margin (%)	9.1%	6.3%	9.8%	12.0%	14.4%	15.4%	7.7%	0.8%	4.5%	10.2%
Other Income ⓘ +	13	11	17	9	10	10	11	6	11	18
Exceptional Items ⓘ	0	0	-2	0	0	-9	0	-65	-17	-5
Interest ⓘ	38	28	33	33	36	24	16	36	48	61
Depreciation ⓘ	46	40	41	42	51	51	52	56	62	66
Profit Before Tax ⓘ	-15	-14	24	59	94	137	53	-138	-55	44
Tax ⓘ	3	-1	13	2	12	32	8	-16	-25	12
Profit After Tax	-18	-14	10	57	82	104	45	-122	-30	32
PAT Margin (%)	-3.0%	-2.0%	1.2%	5.5%	7.0%	7.7%	3.2%	-8.6%	-2.2%	2.1%
Adjusted EPS (₹)	-0.8	-0.6	17.3	2.0	2.8	3.8	1.7	-4.9	-1.4	0.9
Dividend Payout Ratio (%)	0%	0%	1.20%	10.20%	0%	13%	0%	0%	0%	0%

Valuation of Viyash Scientific - Consolidated

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	922	961	630	688	673	720	645	642	579	608
Share Capital ⓘ	48	49	49	49	50	50	50	50	50	50
Reserves ⓘ	874	912	581	638	623	670	595	593	529	558
Debt +	267	360	256	275	297	197	282	332	389	435
Long Term Debt	211	165	104	148	150	94	122	150	143	274
Short Term Debt	56	195	152	127	147	103	160	182	246	161
Minority Interest	2	17	37	40	45	49	48	50	56	66
Trade Payables	144	203	160	209	220	227	258	244	251	257
Others Liabilities ⓘ	203	362	259	189	228	251	254	214	256	207
Total Liabilities ⓘ	1,538	1,904	1,343	1,402	1,463	1,443	1,487	1,484	1,531	1,572
Fixed Assets
Net Fixed Assets ⓘ +	586	684	476	498	577	536	564	605	592	586
Gross Block	644	790	582	638	762	753	825	940	959	1,003
Accumulated Depreciation	57	105	106	140	186	218	261	335	367	417
CWIP ⓘ	24	33	18	23	13	31	12	55	16	16
Investments ⓘ	428	428	239	180	171	83	38	0	4	0
Inventories	135	161	159	200	219	264	348	346	346	385
Trade Receivables	192	255	258	278	319	346	329	341	336	363
Cash Equivalents	25	47	42	72	76	56	59	42	70	69
Others Assets ⓘ	148	296	150	151	88	127	136	94	168	153
Total Assets ⓘ	1,538	1,904	1,343	1,402	1,463	1,443	1,487	1,484	1,531	1,572

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-0	-7	45	116	115	115	31	17	31	83
PBT ⓘ	-14	-17	446	59	94	145	53	-138	-55	44
Adjustment ⓘ	84	123	-314	84	91	84	94	221	145	155
Changes in Working Capital ⓘ	-71	-104	-78	-28	-58	-71	-89	-52	-46	-88
Tax Paid ⓘ	1	-9	-9	1	-12	-44	-27	-15	-14	-28
Cash Flow From Investing Activity ⓘ +	-316	-116	7	-68	-72	10	-96	-65	-6	-25
Capex	-96	-75	-45	-24	-40	-45	-31	-75	-12	-29
Net Investments	-119	7	48	12	-39	53	-41	24	-8	2
Others ⓘ	-101	-48	4	-56	7	2	-23	-14	14	2
Cash Flow From Financing Activity ⓘ +	309	147	-57	-20	-43	-139	67	32	-1	-61
Net Proceeds from Shares ⓘ	540	41	1	2	2	10	11	0	0	7
Net Proceeds from Borrowing ⓘ	-29	20	-51	45	0	-74	36	22	-4	80
Interest Paid ⓘ	-40	-37	-33	-26	-33	-23	-16	-36	-45	-51
Dividend Paid ⓘ	0	0	-5	0	-5	0	-12	-0	-0	-2
Others ⓘ	-162	124	31	-40	-7	-53	48	46	48	-95
Net Cash Flow ⓘ	-7	24	-5	28	0	-14	2	-16	23	-2

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	-3.67	-1.47	1.28	8.63	12.06	15	6.56	-18.95	-4.85	5.44
ROCE (%)	2.5	1.05	4.84	9.24	12.59	16.24	7.01	-9.71	-0.6	9.3
Asset Turnover Ratio	0.51	0.4	0.52	0.77	0.84	0.96	0.98	0.98	0.94	1.03
PAT to CFO Conversion(x)	N/A	N/A	4.5	2.04	1.4	1.11	0.69	N/A	N/A	2.59
Working Capital Days
Receivable Days	90.40	118.40	110.20	92.50	90.50	87.40	85.50	84.10	87.50	79.80
Inventory Days	67.40	78.40	68.60	61.90	63.60	63.60	77.50	87.10	89.50	83.50
Payable Days	143.30	177.50	143.60	124.30	129.60	117.50	111.60	110	119	114.20

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Viyash Scientific Ltd FAQs

The current trading price of Viyash Scientific on 05-Jun-2026 16:59 is ₹255.2.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Jun-2026 the market cap of Viyash Scientific stood at ₹10,886.9 Cr

The latest P/E ratio of Viyash Scientific as of 04-Jun-2026 is 143.5.

The latest P/B ratio of Viyash Scientific as of 04-Jun-2026 is 3.41.

The 52-week high of Viyash Scientific is ₹277.1 and the 52-week low is ₹166.2.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Viyash Scientific is ₹1,382 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Viyash Scientific Ltd is a average quality company.

The key valuation ratios of Viyash Scientific Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Viyash Scientific Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About Viyash Scientific Ltd

P I Drugs & Pharmaceuticals Ltd. established in 1991 is a leading manufacturer, exporter of specialized quality formulations having an objective of fulfilling the diverse demands of pharmaceutical industry.

P I Drugs & Pharmaceuticals Ltd. specializes in the manufacturing of the formulation belonging to anthelmintic & anti-parasitic segment.

In September 2007 PI Drugs purchased the pharma division of Transchem Limited.

The company is engaged in the business of human health & animal health and enjoys high Image for distribution in domestic as well as international markets.

They have a specialized and dedicated WHO - GMP accredited manufacturing plant for the manufacture of API's. It exports to all major markets like Europe, South America, Australia, Asia and Africa.

They started with the introduction of Albendazole and has developed core competency in chemistry of Benzimadazole in very short time.

Product range of the company includes:

Human / Veterinary Formulations

Diminazene Diaceturate
Toldimfos Sodium
Quinapyramine
Triclabendazole
Albendazole
Fenbendazole
Oxyclozanide
Niclosamide
Frusemide
Mebendazole

Honey Bee Medicine

PizitolÂ®
ApistonicÂ®
TransprimÂ®

Human / Veterinary API's

Veterinary APIâ€™s

Albendazole USP/EP/BP
Fenbendazole BP/ EP/BP VET
Oxfendazole EP/BP VET
Mebendazole USP/EP/BP/POLY 'C'

Human API's

Pentamidine Isethionate
Ramipril EP / BP
Frusemide USP / EP / BE
Cetrizine DI HCL BP / EP

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Viyash Scientific Ltd (VIYASH)

Viyash Scientific Ltd (VIYASH)

Viyash Scientific stock performance

Check Before You Invest

Quality

Valuation

Price Trend

DeciZen - make an informed investing decision on Viyash Scientific

1. Right Stock

2. Right Price

3. Right Time ⓘ

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Viyash Scientific - Consolidated

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Viyash Scientific Ltd FAQs

What is the share price of Viyash Scientific?

What is the market cap of Viyash Scientific?

What is the P/E ratio of Viyash Scientific?

What is the P/B ratio of Viyash Scientific?

What is the 52-week high and low of Viyash Scientific?

What is the TTM revenue of Viyash Scientific?

Is Viyash Scientific Ltd a good quality company?

Is Viyash Scientific Ltd undervalued or overvalued?

Is Viyash Scientific Ltd a good buy now?

About Viyash Scientific Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.